Vanguri RS, Fenn KM, Kearney MR, Wang Q, et al. Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer. Clin Breast Cancer 2022 Apr 18. pii: S1526-8209(22)00071.
PMID: 35610143